videosVIDEOS

video title

New Immunotherapeutic Targets in Melanoma

Data emerging to possibly identify new mechanisms of action in melanoma

START 
video title

New Data in Adjuvant Treatment of Melanoma

Debate between immunotherapy, targeted therapy exists in adjuvant melanoma

START 
video title

Combination Approaches and Future Treatment of HNSCC

Reliable model needed to identify effectiveness of combination approaches in head, neck cancer

START 
video title

Current State of Recurrent and Metastatic Head and Neck Cancer Treatment

Recurrent, metastatic head and neck cancer treatment is challenging with only few available options

START 
video title

Who is Eligible to Receive Immunotherapy?

More inclusive eligibility criteria needed in immunotherapy trials

START 
video title

Side Effects of Immunotherapy Agents

Collaboration plays a role in identifying, managing immunotherapy toxicities

START 
video title

Practical Considerations for Immunotherapy

Practical considerations for assessing response, managing toxicities

START 
video title

Case Examples of Immune-Related Side Effects

Case Examples of Immune-Related Side Effects

START 
video title

Basic Immunology for the Non-Immunologist

Basic Immunology for the Non-Immunologist

START 
video title

Biomarkers and Immunotherapy

Identifying, incorporating biomarkers in immuno-oncology

START 
video title

Adoptive T-cell Therapy

What is "adoptive T-cell therapy"?

START 
video title

Tumor Types Treated with CAR T Therapy

Which tumor types are currently best treated with CAR T therapy?

START 
video title

Transforming Cancer Therapy with CAR T Cells

How do you believe the use of CAR T cells will transform cancer therapy?

START 
video title

Developing CAR T Therapies

What obstacles are present in developing effective CAR T therapies?

START 
video title

Cancer Vaccines

How do cancer vaccines function?

START 
video title

Finding Reliable Biomarkers

What challenges are presented by finding reliable biomarkers?

START 
video title

Immune-Related Biomarkers

How can immune-related biomarkers guide patient selection?

START 
video title

Neoantigens

What are neoantigens?

START 
video title

Tumor-Specific Neoantigens

How are tumor-specific neoantigens identified?

START 
video title

Immuno-Oncologic Therapy Research

What are some of the new areas of immuno-oncologic therapy research?

START 
video title

Checkpoint Inhibitors

What are the the different types of checkpoint inhibitors and how do they function?

START 
video title

Immunotherapeutic Agents in Melanoma

Please discuss currently approved immunotherapeutic agents in melanoma.

START 
video title

Types of Cancer Immunotherapy

Can you describe the different types of cancer immunotherapy?

START 
video title

Cytokines

Please discuss cytokines and their several functional groups.

START 
video title

Immunotherapeutic Agents in Head and Neck Cancers

Please discuss currently approved immunotherapeutic agents in head and neck cancers.

START 
video title

Cancer-Immunity Cycle

Please explain the cancer-immunity cycle.

START 
video title

Immunotherapeutic Agents in Lung Cancer

Please discuss currently approved immunotherapeutic agents in lung cancer.

START 
video title

Types of Molecular Testing

What are the different types of molecular testing and how do they aid in treatment selection?

START 
video title

Monoclonal and Bispecific Antibodies

Please describe the difference between naked monoclonal antibodies and bispecific antibodies.

START 
video title

Biomarkers Predicting Clinical Benefit

What challenges are presented with identifying biomarkers predicting clinical benefit in the context of checkpoint inhibitors?

START 
video title

Combination Therapies Used with Checkpoint Inhibitors

Please describe combination therapies used in conjunction with checkpoint inhibitors.

START 
video title

Antiviral and Therapeutic Cancer Vaccines

Please discuss antiviral vaccines and therapeutic cancer vaccines.

START 
video title

Immunotherapy vs. Chemotherapy

How should oncologists talk to patients about the differences between immunotherapy vs. chemotherapy?

START